News
Real-time feed summarized and tagged.
- CNBC6/8/2026, 9:40:05 AMWeight loss drug maker sinks 25% after new safety data spooks investors
An unnamed weight loss drug maker's stock fell 25% after new safety data revealed concerning side effects for its experimental drug, despite the drug meeting its primary efficacy endpoints. Analysts are questioning the commercial viability of the drug given the side effect profile. No specific company or ticker is named in the article.
Yesterday markets, in your inbox.
Top-discussed tickers and the AI sentiment we read. Not advice.